Answers are grounded in this paper and cite their sources.
Ischemic stroke is increasingly recognized not only as a cerebrovascular event but also as a neuropsychiatric condition, with up to one-third of survivors developing significant anxiety or depression. The recent study by Zhao et al published in World Journal of Psychiatry provides important mechanistic insight into how structural, inflammatory, and neuroendocrine disturbances converge to shape post-stroke emotional outcomes. By integrating neuroimaging, clinical phenotyping, and biomarker profiling in patients, the authors identify a multidimensional vulnerability architecture connecting frontal-limbic infarcts, hemispheric lateralization, and white matter disruption with elevated interleukin-6, tumor necrosis factor-alpha, and cortisol, alongside reduced IGF-1. These interacting pathways highlight neuroinflammation- and HPA-axis-driven circuit dysfunction as central processes underlying early post-stroke affective disturbances. The study advances the field by demonstrating that neural circuit injury and cross-system biological dysregulation can be quantified to form clinically meaningful risk indicators, positioning inflammatory markers, cortisol rhythms, and lesion topology as potential early screening tools. Clinically, it underscores the need for integrated neuropsychiatric assessment and timely interventions targeting both biological and psychosocial pathways in the acute recovery window. Future translational work combining longitudinal imaging with biomarker panels may enable precision risk stratification and personalized prevention strategies for post-stroke anxiety and depression.
No takes yet. Share an insight, caveat, or question.
Fang-ling et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: